M. Arredouani

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model

G. Dranoff, M. Sanda, S. Balk, 2022, Cancer Immunology, Immunotherapy.

Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells

J. Ceuppens, S. Vleeschouwer, S. Gool, 2005, Cancer Immunology, Immunotherapy.

Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide

M. Sanda, S. Balk, I. Schmidt-Wolf, 2010, PloS one.